# OnCo record jmbi-001 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/jmbi-001/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "jmbi-001" ;
  schema:name "JMBI-001"@en ;
  schema:description "JMBI-001 is an experimental oral tablet from Anticancer Bioscience, in phase 1 trials for MYC-positive advanced solid tumours and relapsed or refractory non-Hodgkin lymphoma."@en ;
  schema:url <https://onco.cc/drugs/jmbi-001/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07864701>, <https://www.anticancerbio.com/>, <https://clinicaltrials.gov/search?intr=JMBI-001> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Oral tablet (small molecule not stated)" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:companies <https://onco.cc/companies/anticancer-bioscience/> ;
  onco:trials <https://onco.cc/trials/nct07864701/> .